Switch to:
Myriad Genetics Inc (NAS:MYGN)
EV/EBITDA
12.87 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Myriad Genetics Inc's enterprise value is $2,282.1 Mil. Myriad Genetics Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2015 was $177.3 Mil. Therefore, Myriad Genetics Inc's EV/EBITDA ratio for today is 12.87.

MYGN' s EV/EBITDA Range Over the Past 10 Years
Min: -161.3   Max: 38.5
Current: 12.89

-161.3
38.5

During the past 13 years, the highest EV/EBITDA Ratio of Myriad Genetics Inc was 38.50. The lowest was -161.30. And the median was 9.15.

MYGN's EV/EBITDA is ranked higher than
56% of the 179 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 14.20 vs. MYGN: 12.89 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Myriad Genetics Inc's stock price is $34.21. Myriad Genetics Inc's earnings per share for the trailing twelve months (TTM) ended in Sep. 2015 was $1.24. Therefore, Myriad Genetics Inc's P/E Ratio for today is 27.59.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Myriad Genetics Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=2282.135/177.338
=12.87

Myriad Genetics Inc's current Enterprise Value is $2,282.1 Mil.
Myriad Genetics Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2015 was 42.3 (Dec. 2014 ) + 42.129 (Mar. 2015 ) + 42.809 (Jun. 2015 ) + 50.1 (Sep. 2015 ) = $177.3 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Myriad Genetics Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=34.21/1.24
=27.59

Myriad Genetics Inc's share price for today is $34.21.
Myriad Genetics Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2015 was 0.32 (Dec. 2014 ) + 0.29 (Mar. 2015 ) + 0.26 (Jun. 2015 ) + 0.37 (Sep. 2015 ) = $1.24.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Myriad Genetics Inc Annual Data

Jun06Jun07Jun08Jun09Jun10Jun11Jun12Jun13Jun14Jun15
ev2ebitda -18.79-76.2622.9224.657.059.778.577.579.2813.81

Myriad Genetics Inc Quarterly Data

Sep13Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15
ev2ebitda 5.344.017.859.2811.3111.8513.3913.8113.790.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK